期刊文献+

不同标准评估Ⅰ型心肾综合征危险因素研究 被引量:3

Independent common risk factors for the diagnosis of type Ⅰ cardiorenal syndrome by different criteria
原文传递
导出
摘要 目的探讨急性肾损伤(AKI)不同国际标准确定Ⅰ型心肾综合征(CRS)的独立危险因素。方法回顾性分析2005年7月至2012年7月广东省人民医院和中山大学第一附属医院急性心力衰竭(AHF)患者的资料。以危险、损伤、衰竭、肾功能丧失、终末期肾病(RIFLE),及急性肾损伤国际组织(AKIN)、改善全球肾脏病预后组织(KDIGO)标准定义的AKI作为主要观察终点,入院前3个月内的最低血肌酐(Scr)或入院首次Scr为基线Scr。结果共入组1058例患者。KDIGO标准(52.8%)比RIFLE(37.4%)和AKIN标准(47.9%)诊断出更多的AKI患者。Logistic回归分析表明,冠心病、血浆白蛋白(ALB)<30 g/L(OR=1.437)、C反应蛋白(CRP)>29.9 mg/L(OR=2.328)、血尿酸>479μmol/L(OR=1.813)、血红蛋白(Hb)<110 g/L(OR=1.582)、入院后48 h内使用利尿剂(OR=1.499)、血管活性药物(OR=2.124)是RIFLE诊断Ⅰ型CRS的独立影响因素;ALB<30 g/L(AKIN:OR=1.490;KDIGO:OR=1.386)、Hb<110 g/L(AKIN:OR=1.963;KDIGO:OR=1.889)、CRP>29.9 mg/L(AKIN:OR=2.252;KDIGO:OR=2.681)、eGFR<60 mL/(min·1.73 m2)、尿酸>479μmol/L(AKIN:OR=3.317;KDIGO:OR=2.853)、入院后48 h内使用利尿剂(AKIN:OR=3.200;KDIGO:OR=1.556)、血管活性药物(AKIN:OR=1.907;KDIGO:OR=2.040)是AKIN、KDIGO诊断Ⅰ型CRS的独立影响因素。结论 CRP>29.9 mg/L、尿酸>479μmol/L、ALB<30 g/L、Hb<110 g/L、入院后48 h内使用利尿剂和血管活性药物可能是RIFLE、AKIN、KDIGO标准诊断Ⅰ型CRS的共同独立危险因素。 Objective To explore independent common risk factors for the diagnosis of type I cardiorenal syndrome by RI- FLE, AKIN and KDIGO criteria on acute kidney injury (AKI). Methods Data were retrospectively collected from patients with acute heart failure in Guangdong General Hospital and the First Affiliated Hospital of Sun Yat-sen University between July 2005 and July 2012. AKI defined by RIFLE ,AKIN and KDIGO criteria was regarded as the end of observation ,and serum ereatinine was defined by the lowest serum creatinine 3 months before admission or the serum creatinine on admission. Results Among 1058 patients, more patients were diagnosed with AKI by KDIGO criteria (52. 8% ) than by RIFLE (37.4%) or AKIN criteria (47.9%). Logistic regression analysis indicated that coronary heart disease, albumin 〈 30 g/L (Odds Ratio[OR] 1. 437) ,C reactive protein 〈29. 9 mg/L (OR 2. 328) ,uric acid 〉479 p.mol/L (OR 1. 813) ,hemoglobin 〈 110 g/L ( OR 1. 582), use of diuretics ( OR 1. 499 ) and vasoactive agents ( OR 2. 124) within 48 hours after admission were independent factors for the diagnosis of type I cardiorenal syndrome by RIFLE ; albumin 〈 30 g/L ( AKIN : OR 1. 490 ; KDIGO : OR1. 386 ), hemoglobin 〈 110 g/L ( AKIN : OR 1. 963 ; KDIGO : OR 1. 889 ) , C reactive protein 〈 29. 9 mg/L(AKIN: OR 2. 252; KDIGO: OR 2. 681 ), estimated glomerular filtration rate (eGFR) 〈 60 mL/( min · 1.73 m^2) ,uric acid 〉479 μmol/L (AKIN:OR 3. 317;KDIGO:OR 2. 853) ,use of diuretics (AKIN:OR 3. 200;KDIGO:OR 1. 556) and vasoactive agents ( AKIN : OR 1. 907 ; KDIGO : OR 2. 040) within 48 hours after admission might be independent factors for the diagnosis of type I cardiorenal syndrome by AKIN and KDIGO. Conclusion Albumin 〈 30 g/L, hemoglobin 〈 110 g/L, C-reactive protein 〈 29. 9 mg/L, uric acid 〉 479 μmol/L, use of diuretics and vasoactive agents within 48 hours after admission are independent common risk factors for the diagnosis of type I cardiorenal syndrome by RIFLE, AKIN and KDIGO criteria.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2013年第12期953-956,共4页 Chinese Journal of Practical Internal Medicine
基金 国家自然科学基金(81170683) 广州市科技计划项目(2013J4100064)
关键词 I型心肾综合征 RIFLE标准 AKIN标准 KDIGO标准 危险因素 type I cardiorenal sydrome RIFLE criteria AKIN criteria KDIGO criteria risk factors
  • 相关文献

参考文献21

  • 1Ronco C, McCullough P, Anker SD,et al. Cardio-renal syndromes :report from the consensus conference of the acute dialysis quality in-itiative [J]. Eur Heart J,2010,31(6) :703 -711.
  • 2Bellomo R,Ronco C,Kellum JA,et al. Acute renal failure-definiton,outcome measures,animal models,fluid therapy and informationtechnology needs: theSecond International Consensus Conference ofthe Acute Dialysis Quality Initiative ( ADQI) Group [ J]. CriticalCare,2004,8(4) :R204-R212.
  • 3Mehta RL, Kellum JA, Shah SY, et al. Acute Kidney Injury Net-work :report of an initiative to improve outcomes in acute kidney in-jury [J]. Critical Care,2007,11(2) :R31.
  • 4Khwaja. KDIGO clinical practice guidelines for acute kidney injury[J]. Nephron Clin Pract,2012 ,120(4) : 179 -184.
  • 5Metra M,Nodari S,Parrinello G, et al. Worsening renal function inpatients hospitalised for acute heart failure : clinical implications andprognostic significance [ J]. Eur J Heart Fail. 2008 ,10(2) : 188 -195.
  • 6Wang YN,Cheng H,Yue T,et al. Derivation and validation of a pre-diction score for acute kidney injury in patients hospitalized with a-cute heart failure in a Chinese cohort [ J]. Nephrology ( Carlton).2013,18(7) :489 -496.
  • 7Li GS,Chen XL,Zhang Y,et al. Malnutrition and inflammation in a-cute kidney injury due to earthquake-related crush syndrome [ J].BMC Nephrol.2010,11:4.
  • 8Gao F,Zhou YJ,Zhu X,et al. C-reactive protein and the risk of con-trast-induced acute kidney injury in patients undergoing percutane-ous coronary intervention[ J]. Am J Nephrol. 2011,34 ( 3 ) : 203 -210.
  • 9Grazia MV,Rossella T,Cruz DN,et al. Cardiorenal Syndrome Type 1May Be Immunologically Mediated: A Pilot Evaluation of MonocyteApoptosis [ J]. Cardiorenal Med,2012 ;2( 1 ) :33 -42.
  • 10Ejaz AA,Kambhampati G,Ejaz NI,et al. Post-operative serum uricacid and acute kidney injury [ J]. J Nephrol. 2012,25 (4) :497 -505.

二级参考文献6

  • 1Ronco C, Chionh CY, Haapio M, et al. Cardiorenal syndrome [ J ]. Blood Purif,2009,27 : 114 - 126.
  • 2Kociol R,Rogers J, Shaw A. Organ cross talk in the critically ill: the heart and kidney [ J ]. Blood Purif,2009 ,27 :311 - 320.
  • 3Domanski M, Norman J, Pitt B, et al. Studies of left ventricular dysfunction : diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD) [J]. J Am Coll Cardiol,2003 ,42 :705 - 708.
  • 4Liang KV, Williams AW, Greene EL, et al. Acute decompensated heart failure and the cardiorenal syndrome [J]. Crit Care Med, 2008,36 : S75 - S88.
  • 5Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid-management strategies in acute lung injury[ J ]. N Engl J Med,2006,354 : 2564 - 2575.
  • 6Witteles RM, Kao D, Christopherson D, et al. Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction. A randomized, doubleblind,placebo-controlled clinical trial [J]. J Am Coll Cardiol, 2007,50 : 1835 - 1840.

共引文献5

同被引文献23

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部